Articles Archives - Page 205 of 715

FridayNov 18, 2022 11:15 am

DGE’s 2nd Advancing Diversity Equity & Inclusion In Pharma & Healthcare Summit

DE&I leaders, executives, and professionals from the pharma, biotech, healthcare, and allied industries, are invited to the 2nd Advancing Diversity Equity & Inclusion (“ADEI”) In Pharma and Healthcare Summit. This online live-streaming event will be held on December 8-9, 2022. The agenda will guide you to move from awareness towards advocacy and action, as you build a culture of representation and inclusion for success in the workplace and clinical trial management. Professionals and industry experts from the medical realm gather on this forum to discuss and explore ways to attain success and improve the patient’s overall experience. This live-streaming event…

FridayNov 18, 2022 10:30 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Modular Green Ammonia System Represents Needed and Timely Solution to Global Food and Energy Resilience

FuelPositive Corp. is a Canadian developer of clean energy solutions, focusing on an on-site system for producing hydrogen-dense green ammonia The company’s modular system can produce 300 kg per day (500 liters per day) of liquid anhydrous carbon-free ammonia — the amount needed to fertilize a 2,000-acre farm The system’s ability to grant end users greater energy independence as a climate-friendly resource is filling a market need at an opportune time as industries struggle to manage supply chain challenges created by COVID and the ongoing Russia-Ukraine war The module is being tested in a pilot project by Canadian farmers and…

FridayNov 18, 2022 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Head of Technical R&D Presents Flagship NanoAbs Platform at Recent RAFT Conference

The presentation focused on BiondVax’s yeast fermentation system to manufacture innovative alpaca-derived recombinant nanosized VHH-antibodies (NanoAbs) and highlighted the company’s NanoAbs as a platform for development of therapeutics addressing diseases with large unmet medical needs and attractive commercial opportunities BiondVax’s lead NanoAb candidate, an inhaled COVID-19 treatment, exhibits significant competitive advantages over currently available mAbs and oral COVID-19 therapies Development of additional NanoAbs, targeting psoriasis, asthma, psoriatic arthritis and wet macular degeneration is underway via a strategic collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Gottingen (“UMG”), both in Germany BiondVax Pharmaceuticals (NASDAQ: BVXV),…

FridayNov 18, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Sees Jump in Q3 Revenue, Big Demand for its Distributed Energy Solutions

While governmental leaders continue to work toward measurable climate progress, U.S.-based Correlate Infrastructure Partners Inc. is helping corporate clients attain ESG successes sought by investors The company recently reported that completion of construction milestones in contracted projects has netted it an 877 percent jump in revenues from Q2 to Q3, amounting to a 15,024 percent increase YOY CIPI’s efforts include helping clients achieve significant yet affordable change in their facilities’ utilities usage through improvements to mechanical, electrical, and plumbing processes, the addition of solar upgrades, water optimization, and other strategic measures Nearly a decade has passed since world leaders agreed…

ThursdayNov 17, 2022 9:45 am

New Market Opportunities May Open up for Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) as a Cookie-less Future Fast Approaches

The online advertising ecosystem is transforming as governments worldwide ramp up regulations to rein in collection of consumers' personal data Google's Privacy Sandbox works toward the end of third-party cookies in Chrome, giving rise to a whole new privacy-compliant identity ecosystem As a company driven by the evolution of data privacy and its impact on consumers and companies, Reklaim appears well-positioned to capitalize on emerging market opportunities amid a paradigm shift happening with new privacy laws User privacy is taking the online space by storm as consumers become increasingly conscious about how their online data is harvested and used. As…

ThursdayNov 17, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Approved to Proceed with Human Study Evaluating Effectiveness of Patented DehydraTECH(TM) Technology in Boosting Oral-Tissue Absorption of Nicotine

Lexaria Bioscience recently received Independent Review Board approval for its upcoming human clinical nicotine study, NIC-H22-1, and expects to begin dosing soon The company hopes to evidence that processing purified nicotine with its patented DehydraTECH(TM) drug delivery technology leads to better oral-tissue absorption and reduced negative experiences compared to leading brands currently available on the market, On! and Zyn Last year, Lexaria conducted an animal study evaluating oral nicotine absorption, NIC-A21-1, in which it evidenced that its DehydraTECH technology was ten to twenty times faster in delivering comparable levels of nicotine into the bloodstream than the peak of the concentration-matched…

WednesdayNov 16, 2022 9:45 am

EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQX: EVGIF) FVB Expansion Project Breaks Ground to Provide Lift to Company’s Revenues and EBITDA Amid a Stronger Renewable Natural Gas Market

EverGen commenced construction at its Core RNG Expansion Project at Fraser Valley Biogas; project is advancing on schedule and on budget with expected completion in Q1 2023 Expansion is estimated to double FVB’s capacity to ~160,000 GJ of RNG per year; coupled with new long-term offtake agreement executed in current robust RNG market, it is expected to provide significant boost to company’s revenues and EBITDA As Canada’s early mover, EverGen seeks to consolidate assets across the country and leverage its expertise in designing and optimizing resilient facilities; with team that has seen more than a hundred RNG projects, company boasts…

WednesdayNov 16, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO Participated in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run Following European Clinical Trial Site Activations

CNS Pharmaceuticals CEO John Climaco participated in 5K run on November 5, to show support for brain tumor patients worldwide and help raise funds for research The company recently announced European clinical trial site activations for its potentially pivotal global trial evaluating Berubicin for the treatment of recurring glioblastoma multiforme The pivotal trial will study Berubicin’s results compared to the current study of care, Lomustine Global brain tumor treatment market was valued at $2,946 million in 2022 and is expected to grow to $5,904 million by 2032 Brain and other central nervous system cancers (“CNS”) represent 1.3% of all new…

TuesdayNov 15, 2022 9:45 am

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Is ‘One to Watch’

Arizona Metals owns 100% of two copper and gold exploration projects in mining-friendly Arizona Both projects have excellent infrastructure, including roads, available power and water access Only 3% of the prospectively mineralized trend that hosts the high-grade Kay Mine Deposit has been drilled The company had $60 million in cash as of June 30, 2022, to complete Phase 2 and begin Phase 3 drilling at the Kay Mine Arizona Metals (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine…

TuesdayNov 15, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Offering Affordable and Profitable ESG-Related Energy Solutions Amid Spike in ESG-Focused Investment

In 2021, a third of the world’s assets under management, including the money of growing numbers of huge public pension funds, were invested according to ESG principles, with the year posting the highest expenditure on ESG initiatives globally Correlate recognizes the growing need for businesses to achieve ESG goals and is looking to meet this demand by offering a complete suite of proprietary clean energy assessment solutions, specifically for the commercial real estate industry Its unique data-driven approach draws from proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network that has earned it an opportunity pipeline of…

Site Search

Company Search

Category: Articles